Portfolio Holdings Detail for ISIN IE00BMBKBZ46
Stock Name / Fund iShares S&P 500 Health Care Sector UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IUHE.AS(EUR) CXE
ETF Ticker IUHE(EUR) Euronext Amsterdam

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 Health Care Sector UCITS ETF REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-12-03 (Wednesday)	50,529	USD 36,566,321	USD 36,566,321	0	USD -926,197	USD 723.67	USD 742
2025-12-02 (Tuesday)	50,529	USD 37,492,518	USD 37,492,518	-616	USD -871,858	USD 742	USD 750.11
2025-12-01 (Monday)	51,145	USD 38,364,376	USD 38,364,376	15	USD -1,526,739	USD 750.11	USD 780.19
2025-11-28 (Friday)	51,130	USD 39,891,115	USD 39,891,115	336	USD 37,635	USD 780.19	USD 784.61
2025-11-27 (Thursday)	50,794	USD 39,853,480	USD 39,853,480	0	USD 0	USD 784.61	USD 784.61
2025-11-26 (Wednesday)	50,794	USD 39,853,480	USD 39,853,480	-112	USD -225,832	USD 784.61	USD 787.32
2025-11-25 (Tuesday)	50,906	USD 40,079,312	USD 40,079,312	112	USD 1,402,221	USD 787.32	USD 761.45
2025-11-24 (Monday)	50,794	USD 38,677,091	USD 38,677,091	280	USD 493,558	USD 761.45	USD 755.9
2025-11-21 (Friday)	50,514	USD 38,183,533	USD 38,183,533	0	USD 954,715	USD 755.9	USD 737
2025-11-20 (Thursday)	50,514	USD 37,228,818	USD 37,228,818	56	USD 1,769,458	USD 737	USD 702.75
2025-11-19 (Wednesday)	50,458	USD 35,459,360	USD 35,459,360	0	USD -1,139,846	USD 702.75	USD 725.34
2025-11-18 (Tuesday)	50,458	USD 36,599,206	USD 36,599,206	0	USD 1,061,132	USD 725.34	USD 704.31
2025-11-17 (Monday)	50,458	USD 35,538,074	USD 35,538,074	0	USD 545,451	USD 704.31	USD 693.5

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BMBKBZ46

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 SELL -616 742.000* 641.66 Profit of 395,261 on sale
2025-12-01 BUY 15 779.840 748.210 751.373 USD 11,271 641.18
2025-11-28 BUY 336 780.190* 640.55
2025-11-26 SELL -112 790.980 777.000 778.398 USD -87,181 639.26 Loss of -15,584 on sale
2025-11-26 SELL -112 790.980 777.000 778.398 USD -87,181 639.26 Loss of -15,584 on sale
2025-11-25 BUY 112 790.570 760.700 763.687 USD 85,533 638.59
2025-11-24 BUY 280 773.130 756.640 758.289 USD 212,321 638.03
2025-11-20 BUY 56 737.000* 637.03
2025-11-12 SELL -224 681.720* 635.24 Profit of 142,294 on sale
2025-11-10 BUY 560 665.990 653.190 654.470 USD 366,503 634.96
2025-11-06 BUY 56 657.000 641.260 642.834 USD 35,999 634.79
2025-11-05 SELL -56 646.895 628.000 629.890 USD -35,274 634.75 Profit of 272 on sale
2025-11-04 BUY 56 646.221 625.140 627.248 USD 35,126 634.78
2025-10-31 BUY 285 659.760 645.000 646.476 USD 184,246 634.66
2025-10-30 SELL -342 664.000 645.000 646.900 USD -221,240 634.57 Loss of -4,218 on sale
2025-10-29 SELL -114 652.910 659.980 659.273 USD -75,157 634.47 Loss of -2,827 on sale
2025-10-28 BUY 108 654.480 655.700 655.578 USD 70,802 634.38
2025-10-27 SELL -114 585.310 586.150 586.066 USD -66,812 634.62 Profit of 5,535 on sale
2025-10-22 SELL -57 584.740 588.710 588.313 USD -33,534 635.46 Profit of 2,687 on sale
2025-10-17 SELL -228 578.050 579.040 578.941 USD -131,999 636.35 Profit of 13,089 on sale
2025-10-16 BUY 285 569.170 589.080 587.089 USD 167,320 636.70
2025-10-15 BUY 399 576.420 584.870 584.025 USD 233,026 637.01
2025-10-14 BUY 57 572.600 576.180 575.822 USD 32,822 637.35
2025-10-03 BUY 112 600.000 618.010 616.209 USD 69,015 637.54
2025-10-02 BUY 56 600.000 605.410 604.869 USD 33,873 637.74
2025-10-01 BUY 326 599.940 615.390 613.845 USD 200,113 637.94
2025-09-24 SELL -716 576.980 577.980 577.880 USD -413,762 639.97 Profit of 44,455 on sale
2025-09-18 BUY 57 598.710 600.000 599.871 USD 34,193 640.19
2025-09-12 BUY 151 560.000 570.000 569.000 USD 85,919 641.70
2025-09-11 BUY 57 568.200 570.760 570.504 USD 32,519 642.11
2025-09-10 BUY 57 555.830 560.000 559.583 USD 31,896 642.60
2025-08-20 BUY 114 591.010 596.920 596.329 USD 67,982 643.66
2025-08-19 BUY 57 571.780 581.690 580.699 USD 33,100 644.07
2025-08-18 BUY 285 573.910 585.000 583.891 USD 166,409 644.48
2025-08-15 BUY 849 580.410 581.950 581.796 USD 493,945 644.86
2025-08-14 BUY 342 565.970 573.490 572.738 USD 195,876 645.33
2025-08-13 BUY 228 561.550 565.500 565.105 USD 128,844 645.83
2025-07-30 BUY 58 554.580 563.590 562.689 USD 32,636 646.91
2025-07-17 SELL -58 550.000 554.480 554.032 USD -32,134 652.05 Profit of 5,685 on sale
2025-07-15 SELL -232 547.960 574.750 572.071 USD -132,720 653.39 Profit of 18,867 on sale
2025-07-14 SELL -580 570.590 575.130 574.676 USD -333,312 653.93 Profit of 45,968 on sale
2025-07-09 SELL -58 552.580 558.380 557.800 USD -32,352 655.80 Profit of 5,684 on sale
2025-07-07 SELL -116 538.110 547.590 546.642 USD -63,410 657.31 Profit of 12,838 on sale
2025-07-02 BUY 58 547.740 551.500 551.124 USD 31,965 659.57
2025-06-24 SELL -986 522.270 527.450 526.932 USD -519,555 664.45 Profit of 135,592 on sale
2025-06-23 BUY 58 511.920 516.180 515.754 USD 29,914 665.54
2025-06-20 SELL -491 509.720 521.310 520.151 USD -255,394 666.66 Profit of 71,936 on sale
2025-06-18 SELL -58 513.580 519.170 518.611 USD -30,079 668.89 Profit of 8,716 on sale
2025-06-17 BUY 696 508.860 523.010 521.595 USD 363,030 670.07
2025-06-13 SELL -116 529.240 529.550 529.519 USD -61,424 672.22 Profit of 16,554 on sale
2025-06-11 SELL -58 518.600 528.370 527.393 USD -30,589 674.53 Profit of 8,534 on sale
2025-06-10 SELL -116 523.530 529.990 529.344 USD -61,404 675.68 Profit of 16,975 on sale
2025-06-09 SELL -174 517.600 518.270 518.203 USD -90,167 676.89 Profit of 27,612 on sale
2025-05-21 SELL -57 604.620 617.520 616.230 USD -35,125 691.35 Profit of 4,282 on sale
2025-05-20 SELL -114 614.790 615.450 615.384 USD -70,154 692.01 Profit of 8,735 on sale
2025-05-15 SELL -171 584.990 585.260 585.233 USD -100,075 694.66 Profit of 18,712 on sale
2025-05-14 SELL -171 571.360 580.560 579.640 USD -99,118 695.76 Profit of 19,857 on sale
2025-05-13 BUY 57 574.160 575.050 574.961 USD 32,773 696.86
2025-05-09 SELL -57 527.780 552.840 550.334 USD -31,369 699.52 Profit of 8,504 on sale
2025-05-08 BUY 114 547.670 552.570 552.080 USD 62,937 700.93
2025-05-01 BUY 114 590.000 593.930 593.537 USD 67,663 706.62
2025-04-24 SELL -57 599.760 601.280 601.128 USD -34,264 712.25 Profit of 6,334 on sale
2025-04-23 BUY 171 587.850 603.770 602.178 USD 102,972 713.53
2025-04-15 SELL -57 557.910 575.200 573.471 USD -32,688 723.43 Profit of 8,548 on sale
2025-04-10 SELL -114 546.390 571.990 569.430 USD -64,915 729.10 Profit of 18,202 on sale
2025-04-08 SELL -57 556.810 586.030 583.108 USD -33,237 732.87 Profit of 8,537 on sale
2025-04-07 SELL -57 572.780 591.540 589.664 USD -33,611 734.76 Profit of 8,270 on sale
2025-04-04 SELL -114 573.450 612.990 609.036 USD -69,430 736.68 Profit of 14,551 on sale
2025-04-02 BUY 57 625.600 628.000 627.760 USD 35,782 738.02
2025-04-01 BUY 513 617.000 641.240 638.816 USD 327,713 739.49
2025-03-31 SELL -342 634.230 640.720 640.071 USD -218,904 740.79 Profit of 34,446 on sale
2025-03-28 BUY 57 637.360 642.970 642.409 USD 36,617 742.08
2025-03-26 SELL -36 640.140 644.000 643.614 USD -23,170 744.75 Profit of 3,641 on sale
2025-03-21 BUY 696 658.480 661.000 660.748 USD 459,881 748.49
2025-03-20 BUY 228 662.620 674.830 673.609 USD 153,583 749.65
2025-03-17 SELL -57 678.420 679.830 679.689 USD -38,742 752.94 Profit of 4,175 on sale
2025-03-12 SELL -42 689.500 712.460 710.164 USD -29,827 756.20 Profit of 1,934 on sale
2025-03-07 BUY 57 707.510 729.750 727.526 USD 41,469 757.71
2025-02-28 SELL -171 698.740 708.580 707.596 USD -120,999 762.38 Profit of 9,368 on sale
2025-02-25 BUY 570 723.470 739.000 737.447 USD 420,345 765.03
2025-02-20 BUY 399 696.020 703.140 702.428 USD 280,269 768.40
2025-02-19 BUY 171 685.660 688.670 688.369 USD 117,711 769.94
2025-02-18 BUY 114 680.000 689.950 688.955 USD 78,541 771.63
2025-02-13 BUY 285 674.270 677.690 677.348 USD 193,044 777.50
2025-02-04 BUY 228 697.050 709.980 708.687 USD 161,581 790.92
2025-01-31 BUY 57 672.980 688.000 686.498 USD 39,130 796.82
2025-01-29 BUY 57 687.270 697.570 696.540 USD 39,703 802.55
2025-01-27 BUY 114 684.710 698.450 697.076 USD 79,467 808.87
2025-01-24 BUY 57 675.790 693.840 692.035 USD 39,446 812.57
2025-01-02 SELL -2,323 715.190 726.810 725.648 USD -1,685,680 818.90 Profit of 216,631 on sale
2024-12-10 SELL -57 778.500 791.490 790.191 USD -45,041 820.13 Profit of 1,706 on sale
2024-12-09 SELL -1,482 788.000 800.990 799.691 USD -1,185,142 821.13 Profit of 31,774 on sale
2024-12-03 SELL -684 749.570 770.000 767.957 USD -525,283 829.52 Profit of 42,107 on sale
2024-12-02 SELL -285 762.340 763.890 763.735 USD -217,664 832.00 Profit of 19,457 on sale
2024-11-29 SELL -57 750.220 754.510 754.081 USD -42,983 835.15 Profit of 4,621 on sale
2024-11-22 SELL -570 738.000 751.400 750.060 USD -427,534 855.41 Profit of 60,050 on sale
2024-11-21 SELL -285 744.500 757.560 756.254 USD -215,532 860.96 Profit of 29,840 on sale
2024-11-20 BUY 456 743.350 750.690 749.956 USD 341,980 867.15
2024-11-18 SELL -684 762.000 762.700 762.630 USD -521,639 880.54 Profit of 80,650 on sale
2024-11-11 BUY 513 825.680 834.420 833.546 USD 427,609 888.17
2024-11-08 SELL -1,824 828.420 830.730 830.499 USD -1,514,830 892.43 Profit of 112,970 on sale
2024-11-07 SELL -114 824.480 832.530 831.725 USD -94,817 897.66 Profit of 7,517 on sale
2024-11-01 SELL -114 843.600 862.000 860.160 USD -98,058 927.90 Profit of 7,722 on sale
2024-10-31 SELL -228 838.200 883.150 878.655 USD -200,333 939.11 Profit of 13,784 on sale
2024-10-30 BUY 57 922.790 935.860 934.553 USD 53,270 941.44
2024-10-29 BUY 342 927.330 932.380 931.875 USD 318,701 943.79
2024-10-28 SELL -171 928.610 943.270 941.804 USD -161,048 946.83 Profit of 859 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	SELL	-616			742.000*		641.66 Profit of 395,261 on sale
2025-12-01	BUY	15	779.840	748.210	751.373	USD 11,271	641.18
2025-11-28	BUY	336			780.190*		640.55
2025-11-26	SELL	-112	790.980	777.000	778.398	USD -87,181	639.26 Loss of -15,584 on sale
2025-11-26	SELL	-112	790.980	777.000	778.398	USD -87,181	639.26 Loss of -15,584 on sale
2025-11-25	BUY	112	790.570	760.700	763.687	USD 85,533	638.59
2025-11-24	BUY	280	773.130	756.640	758.289	USD 212,321	638.03
2025-11-20	BUY	56			737.000*		637.03
2025-11-12	SELL	-224			681.720*		635.24 Profit of 142,294 on sale
2025-11-10	BUY	560	665.990	653.190	654.470	USD 366,503	634.96
2025-11-06	BUY	56	657.000	641.260	642.834	USD 35,999	634.79
2025-11-05	SELL	-56	646.895	628.000	629.890	USD -35,274	634.75 Profit of 272 on sale
2025-11-04	BUY	56	646.221	625.140	627.248	USD 35,126	634.78
2025-10-31	BUY	285	659.760	645.000	646.476	USD 184,246	634.66
2025-10-30	SELL	-342	664.000	645.000	646.900	USD -221,240	634.57 Loss of -4,218 on sale
2025-10-29	SELL	-114	652.910	659.980	659.273	USD -75,157	634.47 Loss of -2,827 on sale
2025-10-28	BUY	108	654.480	655.700	655.578	USD 70,802	634.38
2025-10-27	SELL	-114	585.310	586.150	586.066	USD -66,812	634.62 Profit of 5,535 on sale
2025-10-22	SELL	-57	584.740	588.710	588.313	USD -33,534	635.46 Profit of 2,687 on sale
2025-10-17	SELL	-228	578.050	579.040	578.941	USD -131,999	636.35 Profit of 13,089 on sale
2025-10-16	BUY	285	569.170	589.080	587.089	USD 167,320	636.70
2025-10-15	BUY	399	576.420	584.870	584.025	USD 233,026	637.01
2025-10-14	BUY	57	572.600	576.180	575.822	USD 32,822	637.35
2025-10-03	BUY	112	600.000	618.010	616.209	USD 69,015	637.54
2025-10-02	BUY	56	600.000	605.410	604.869	USD 33,873	637.74
2025-10-01	BUY	326	599.940	615.390	613.845	USD 200,113	637.94
2025-09-24	SELL	-716	576.980	577.980	577.880	USD -413,762	639.97 Profit of 44,455 on sale
2025-09-18	BUY	57	598.710	600.000	599.871	USD 34,193	640.19
2025-09-12	BUY	151	560.000	570.000	569.000	USD 85,919	641.70
2025-09-11	BUY	57	568.200	570.760	570.504	USD 32,519	642.11
2025-09-10	BUY	57	555.830	560.000	559.583	USD 31,896	642.60
2025-08-20	BUY	114	591.010	596.920	596.329	USD 67,982	643.66
2025-08-19	BUY	57	571.780	581.690	580.699	USD 33,100	644.07
2025-08-18	BUY	285	573.910	585.000	583.891	USD 166,409	644.48
2025-08-15	BUY	849	580.410	581.950	581.796	USD 493,945	644.86
2025-08-14	BUY	342	565.970	573.490	572.738	USD 195,876	645.33
2025-08-13	BUY	228	561.550	565.500	565.105	USD 128,844	645.83
2025-07-30	BUY	58	554.580	563.590	562.689	USD 32,636	646.91
2025-07-17	SELL	-58	550.000	554.480	554.032	USD -32,134	652.05 Profit of 5,685 on sale
2025-07-15	SELL	-232	547.960	574.750	572.071	USD -132,720	653.39 Profit of 18,867 on sale
2025-07-14	SELL	-580	570.590	575.130	574.676	USD -333,312	653.93 Profit of 45,968 on sale
2025-07-09	SELL	-58	552.580	558.380	557.800	USD -32,352	655.80 Profit of 5,684 on sale
2025-07-07	SELL	-116	538.110	547.590	546.642	USD -63,410	657.31 Profit of 12,838 on sale
2025-07-02	BUY	58	547.740	551.500	551.124	USD 31,965	659.57
2025-06-24	SELL	-986	522.270	527.450	526.932	USD -519,555	664.45 Profit of 135,592 on sale
2025-06-23	BUY	58	511.920	516.180	515.754	USD 29,914	665.54
2025-06-20	SELL	-491	509.720	521.310	520.151	USD -255,394	666.66 Profit of 71,936 on sale
2025-06-18	SELL	-58	513.580	519.170	518.611	USD -30,079	668.89 Profit of 8,716 on sale
2025-06-17	BUY	696	508.860	523.010	521.595	USD 363,030	670.07
2025-06-13	SELL	-116	529.240	529.550	529.519	USD -61,424	672.22 Profit of 16,554 on sale
2025-06-11	SELL	-58	518.600	528.370	527.393	USD -30,589	674.53 Profit of 8,534 on sale
2025-06-10	SELL	-116	523.530	529.990	529.344	USD -61,404	675.68 Profit of 16,975 on sale
2025-06-09	SELL	-174	517.600	518.270	518.203	USD -90,167	676.89 Profit of 27,612 on sale
2025-05-21	SELL	-57	604.620	617.520	616.230	USD -35,125	691.35 Profit of 4,282 on sale
2025-05-20	SELL	-114	614.790	615.450	615.384	USD -70,154	692.01 Profit of 8,735 on sale
2025-05-15	SELL	-171	584.990	585.260	585.233	USD -100,075	694.66 Profit of 18,712 on sale
2025-05-14	SELL	-171	571.360	580.560	579.640	USD -99,118	695.76 Profit of 19,857 on sale
2025-05-13	BUY	57	574.160	575.050	574.961	USD 32,773	696.86
2025-05-09	SELL	-57	527.780	552.840	550.334	USD -31,369	699.52 Profit of 8,504 on sale
2025-05-08	BUY	114	547.670	552.570	552.080	USD 62,937	700.93
2025-05-01	BUY	114	590.000	593.930	593.537	USD 67,663	706.62
2025-04-24	SELL	-57	599.760	601.280	601.128	USD -34,264	712.25 Profit of 6,334 on sale
2025-04-23	BUY	171	587.850	603.770	602.178	USD 102,972	713.53
2025-04-15	SELL	-57	557.910	575.200	573.471	USD -32,688	723.43 Profit of 8,548 on sale
2025-04-10	SELL	-114	546.390	571.990	569.430	USD -64,915	729.10 Profit of 18,202 on sale
2025-04-08	SELL	-57	556.810	586.030	583.108	USD -33,237	732.87 Profit of 8,537 on sale
2025-04-07	SELL	-57	572.780	591.540	589.664	USD -33,611	734.76 Profit of 8,270 on sale
2025-04-04	SELL	-114	573.450	612.990	609.036	USD -69,430	736.68 Profit of 14,551 on sale
2025-04-02	BUY	57	625.600	628.000	627.760	USD 35,782	738.02
2025-04-01	BUY	513	617.000	641.240	638.816	USD 327,713	739.49
2025-03-31	SELL	-342	634.230	640.720	640.071	USD -218,904	740.79 Profit of 34,446 on sale
2025-03-28	BUY	57	637.360	642.970	642.409	USD 36,617	742.08
2025-03-26	SELL	-36	640.140	644.000	643.614	USD -23,170	744.75 Profit of 3,641 on sale
2025-03-21	BUY	696	658.480	661.000	660.748	USD 459,881	748.49
2025-03-20	BUY	228	662.620	674.830	673.609	USD 153,583	749.65
2025-03-17	SELL	-57	678.420	679.830	679.689	USD -38,742	752.94 Profit of 4,175 on sale
2025-03-12	SELL	-42	689.500	712.460	710.164	USD -29,827	756.20 Profit of 1,934 on sale
2025-03-07	BUY	57	707.510	729.750	727.526	USD 41,469	757.71
2025-02-28	SELL	-171	698.740	708.580	707.596	USD -120,999	762.38 Profit of 9,368 on sale
2025-02-25	BUY	570	723.470	739.000	737.447	USD 420,345	765.03
2025-02-20	BUY	399	696.020	703.140	702.428	USD 280,269	768.40
2025-02-19	BUY	171	685.660	688.670	688.369	USD 117,711	769.94
2025-02-18	BUY	114	680.000	689.950	688.955	USD 78,541	771.63
2025-02-13	BUY	285	674.270	677.690	677.348	USD 193,044	777.50
2025-02-04	BUY	228	697.050	709.980	708.687	USD 161,581	790.92
2025-01-31	BUY	57	672.980	688.000	686.498	USD 39,130	796.82
2025-01-29	BUY	57	687.270	697.570	696.540	USD 39,703	802.55
2025-01-27	BUY	114	684.710	698.450	697.076	USD 79,467	808.87
2025-01-24	BUY	57	675.790	693.840	692.035	USD 39,446	812.57
2025-01-02	SELL	-2,323	715.190	726.810	725.648	USD -1,685,680	818.90 Profit of 216,631 on sale
2024-12-10	SELL	-57	778.500	791.490	790.191	USD -45,041	820.13 Profit of 1,706 on sale
2024-12-09	SELL	-1,482	788.000	800.990	799.691	USD -1,185,142	821.13 Profit of 31,774 on sale
2024-12-03	SELL	-684	749.570	770.000	767.957	USD -525,283	829.52 Profit of 42,107 on sale
2024-12-02	SELL	-285	762.340	763.890	763.735	USD -217,664	832.00 Profit of 19,457 on sale
2024-11-29	SELL	-57	750.220	754.510	754.081	USD -42,983	835.15 Profit of 4,621 on sale
2024-11-22	SELL	-570	738.000	751.400	750.060	USD -427,534	855.41 Profit of 60,050 on sale
2024-11-21	SELL	-285	744.500	757.560	756.254	USD -215,532	860.96 Profit of 29,840 on sale
2024-11-20	BUY	456	743.350	750.690	749.956	USD 341,980	867.15
2024-11-18	SELL	-684	762.000	762.700	762.630	USD -521,639	880.54 Profit of 80,650 on sale
2024-11-11	BUY	513	825.680	834.420	833.546	USD 427,609	888.17
2024-11-08	SELL	-1,824	828.420	830.730	830.499	USD -1,514,830	892.43 Profit of 112,970 on sale
2024-11-07	SELL	-114	824.480	832.530	831.725	USD -94,817	897.66 Profit of 7,517 on sale
2024-11-01	SELL	-114	843.600	862.000	860.160	USD -98,058	927.90 Profit of 7,722 on sale
2024-10-31	SELL	-228	838.200	883.150	878.655	USD -200,333	939.11 Profit of 13,784 on sale
2024-10-30	BUY	57	922.790	935.860	934.553	USD 53,270	941.44
2024-10-29	BUY	342	927.330	932.380	931.875	USD 318,701	943.79
2024-10-28	SELL	-171	928.610	943.270	941.804	USD -161,048	946.83 Profit of 859 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.